☆ 4.2 Article

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder

ADDICTION SCIENCE & CLINICAL PRACTICE (2023)

Related references

Note: Only part of the references are listed.

Article Substance Abuse

Clinical Management of Opioid Withdrawal

Kristine E. Torres-Lockhart et al.

Summary: Appropriate clinical management is essential for opioid withdrawal, as it reduces the risks of overdose and relapse. This narrative review provides evidence-based strategies for opioid withdrawal management, including complex cases, relapse prevention, and new developments.

ADDICTION (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Treating Opioid Withdrawal in the Hospital: A Role for Short-Acting Opioids

Robert A. Kleinman et al.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Substance Abuse

Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report

Rachel Ehrman-Dupre et al.

Summary: This case study presents a successful management of xylazine withdrawal in a hospitalized patient with opioid use disorder and chronic xylazine use. It highlights the importance of addressing medical concerns related to chronic xylazine use and provides valuable insights for the clinical treatment of patients with long-term xylazine use.

JOURNAL OF ADDICTION MEDICINE (2022)

Add to Collection

Review Substance Abuse

Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach

Shawn M. Cohen et al.

Summary: Low dose buprenorphine initiation is an alternative method that gradually increases the treatment dose, avoiding opioid withdrawal symptoms and allowing simultaneous use of full opioid agonists. However, there is limited evidence and a need for clear usage guidelines.

JOURNAL OF ADDICTION MEDICINE (2022)

Add to Collection

Article Substance Abuse

Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl

Neil B. Varshneya et al.

Summary: This study evaluated the incidence of buprenorphine-precipitated withdrawal in individuals who use fentanyl. The results showed that taking buprenorphine within 24 hours or 24 to 48 hours after fentanyl use significantly increased the odds of severe withdrawal symptoms. In contrast, patients taking methadone did not report significantly higher rates of withdrawal after fentanyl use.

JOURNAL OF ADDICTION MEDICINE (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder

Ashish P. Thakrar

JAMA INTERNAL MEDICINE (2022)

Add to Collection

Letter Substance Abuse

Opioid withdrawal management in the fentanyl era

Ashish P. Thakrar et al.

ADDICTION (2022)

Add to Collection

Review Medicine, General & Internal

Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines

Susan L. Calcaterra et al.

Summary: Hospitalizations related to opioid use are increasing, but guidelines for in-hospital management of opioid use disorder (OUD) are lacking. This study aimed to evaluate the quality and content of existing guidelines for OUD treatment and management. The results showed that the included guidelines were primarily based on observational studies or expert consensus, and provided various recommendations, such as using nonstigmatizing language, assessing patients using specific criteria, and using specific medications for treatment. Further research is needed to explore treatment strategies in different settings.

JOURNAL OF HOSPITAL MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association

Larry M. Baddour et al.

Summary: This article introduces the scientific statement sponsored by the American Heart Association on the management of infective endocarditis in people who inject drugs. The statement emphasizes the need for a unique approach in treating infective endocarditis, including the involvement of various specialists and consultation with addiction-trained clinicians. Preventive measures are crucial for individuals who inject drugs.

CIRCULATION (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Hospital Standards of Care for People with Substance Use Disorder

Honora Englander et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Substance Abuse

Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series

Rupinder Brar et al.

Summary: This study explored the effectiveness of initiating iOAT in a hospital setting for treatment refractory individuals with severe OUD, showing that all participants stayed until recommended discharge after iOAT initiation, with an average total dose of intravenous hydromorphone used during titration being 100 mg on day 1, and 200 mg on days 2 to 3. All patients continued iOAT treatment post-discharge.

JOURNAL OF ADDICTION MEDICINE (2021)

Add to Collection

Article Substance Abuse

Hospital-based Buprenorphine Micro-dose Initiation

Melissa B. Weimer et al.

Summary: Initiating low-dose buprenorphine in the hospital setting is a novel strategy that facilitates transitioning from full opioid agonists to buprenorphine.

JOURNAL OF ADDICTION MEDICINE (2021)

Add to Collection

Editorial Material Substance Abuse

High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers

Laura E. Labonte et al.

Summary: Individuals who use opioids have higher rates of hospitalization due to insufficiently treated withdrawal and pain. Injectable opioid agonist therapy is limited in Canadian communities, but high-dose IV HM may be a useful adjunct therapy in the hospital setting.

HARM REDUCTION JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Assessment of Annual Cost of Substance Use Disorder in US Hospitals

Cora Peterson et al.

Summary: This study estimated the annual attributable medical cost of SUD in US hospitals to be $13.2 billion, with costs varying by substance type. The findings suggest that reductions in high direct medical costs of SUD hospital care could offset the cost of effective prevention and treatment, offering opportunities for treatment during hospitalization for patients with SUD.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Medicine, General & Internal

A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder

Honora Englander et al.

JOURNAL OF HOSPITAL MEDICINE (2020)

Add to Collection

Article Substance Abuse

Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study

Rachel Simon et al.

SUBSTANCE ABUSE (2020)

Add to Collection

Article Multidisciplinary Sciences

National US time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality

Jasvinder A. Singh et al.

PLOS ONE (2020)

Add to Collection

Article Immunology

In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections

Ellen F. Eaton et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

Add to Collection

Article Health Care Sciences & Services

Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis

Kelsey C. Priest et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Add to Collection

Review Emergency Medicine

Emergency Department-initiated Interventions for Patients With Opioid Use Disorder: A Systematic Review

Janusz Kaczorowski et al.

ACADEMIC EMERGENCY MEDICINE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Normalised pain and severe health care delay among people who inject drugs in London: Adapting cultural safety principles to promote care

Magdalena Harris

SOCIAL SCIENCE & MEDICINE (2020)

Add to Collection

Article Substance Abuse

Initiation of injectable opioid agonist treatment in hospital: A case report

Matthew McAdam et al.

DRUG AND ALCOHOL REVIEW (2020)

Add to Collection

Article Psychology, Clinical

Hospitalization outcomes of people who use drugs: One size does not fit all

Elisabeth Merchant et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2020)

Add to Collection

Article Substance Abuse

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update

[Anonymous]

JOURNAL OF ADDICTION MEDICINE (2020)

Add to Collection

Review Emergency Medicine

Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review

Paulyne Lee et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)

Add to Collection

Article Public, Environmental & Occupational Health

US National 90-Day Readmissions After Opioid Overdose Discharge

Cora Peterson et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2019)

Add to Collection

Article Substance Abuse

Everything is not right anymore: Buprenorphine experiences in an era of illicit fentanyl

Sydney M. Silverstein et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2019)

Add to Collection

Article Substance Abuse

Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis

Phillip J. Summers et al.

DRUG AND ALCOHOL DEPENDENCE (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017

Alana M. Vivolo-Kantor et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Leaving the Hospital Against Medical Advice Among People Who Use Illicit Drugs: A Systematic Review

Lianping Ti et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2015)

Add to Collection

Review Chemistry, Medicinal

Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications

Ruben S. Vardanyan et al.

FUTURE MEDICINAL CHEMISTRY (2014)

Add to Collection

Article Public, Environmental & Occupational Health

Hospitals as a 'risk environment': An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs

Ryan McNeil et al.

SOCIAL SCIENCE & MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

Increased Risk of Mortality and Readmission among Patients Discharged Against Medical Advice

William N. Southern et al.

AMERICAN JOURNAL OF MEDICINE (2012)

Add to Collection

Editorial Material Nursing

Assessment of Sedation During Opioid Administration for Pain Management

Chris Pasero

JOURNAL OF PERIANESTHESIA NURSING (2009)

Add to Collection

Article Medicine, General & Internal

Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study

J Strang et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Add to Collection

Article Psychology, Clinical

The clinical opiate withdrawal scale (COWS)

DR Wesson et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2003)

Add to Collection

Article Critical Care Medicine

The Richmond Agitation-Sedation Scale - Validity and reliability in adult intensive care unit patients

CN Sessler et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.